Day: January 30, 2022
PERTH, Western Australia, Jan. 30, 2022 (GLOBE NEWSWIRE) — Perseus Mining Limited (“Perseus” or the “Company”) (ASX/TSX:PRU) is pleased to announce that it has agreed to acquire a 15% interest in Orca Gold Inc (“Orca”) from Resolute Mining Limited (“RSG”). Orca is a gold developer, listed on the TSX Venture Exchange (“TSX-V”). Its key assets include a 70% interest in the Block 14 Gold Project (“Block 14”) in northern Sudan and a 31.5% interest in Montage Gold Corp (“Montage”), which owns the Koné Gold Project in northern Côte d’Ivoire.
Perseus has agreed to acquire 39,092,233 million common shares in Orca from RSG representing 15% of Orca’s common shares on issue (the “RSG Share Acquisition”). The RSG Share Acquisition was executed at a price of approximately 44.8 Canadian cents per Orca share representing the 10-day VWAP of Orca...
Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NAFLD-1 Study of Resmetirom on Monday, January 31st
Written by Customer Service on . Posted in Public Companies.
CONSHOHOCKEN, Pa., Jan. 30, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, plans to announce topline results from the Phase 3 MAESTRO-NAFLD-1 study of resmetirom on Monday, January 31st, 2022.
The schedule for the press release and conference call/webcast is as follows:• MAESTRO-NAFLD-1 Press Release:
January 31st, 2022 at 7:00 am EST• MAESTRO-NAFLD-1 Conference Call:
January 31st, 2022 at 8:00 am EST• Domestic Dial-In Number:
(833) 660-2754• International Dial-In Number:
(409) 350-3497• Conference ID Number:
9170277To access the live webcast of the call please visit the Events and Presentations section of Madrigal’s website or click here. An archived webcast will be available...